Figure 1.
LapOvCa-trial design. * = Physical examination, ultrasound, tumor markers, chest X-ray, abdominal CT. # = Largest residual tumor localization, left behind at the end of cytoreductive surgery, is more than 1 cm in diameter. •Debulking surgery feasible: residual tumor after surgery will be < 1 cm. •Debulking surgery not feasible: residual tumor after surgery will be > 1 cm.